Clinical Trials Logo

Poisoning clinical trials

View clinical trials related to Poisoning.

Filter by:

NCT ID: NCT03497104 Completed - Clinical trials for Paracetamol Overdose

The Markers and Paracetamol Poisoning Study 2

MAPP2
Start date: July 1, 2018
Phase:
Study type: Observational

Paracetamol overdose is one of the most common medical emergencies. Annually in the UK, 100,000 people seek medical attention and 50,000 need hospital admission. Treatment is with the antidote acetylcysteine (NAC), which is effective but takes 21 hours to administer intravenously and frequently produces adverse reactions. Current tools that are used to decide who needs treatment are inadequate. this trial team have identified and validated new blood tests that accurately identify those patients at risk of liver injury by quantifying the fundamental in vivo toxicity mechanisms. This study aim to gain further samples in order to develop a new point-of-care test specifically for the detection of liver damage.

NCT ID: NCT03481192 Active, not recruiting - Suicide Clinical Trials

Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers

IMG-COG
Start date: January 2, 2018
Phase: N/A
Study type: Interventional

To identify in patients admitted for Voluntary drug poisoning (IMV) by psychoactive substances, T1 predictors of T2 recall of psychiatric interview and care project.

NCT ID: NCT03408275 Completed - Pregnancy Related Clinical Trials

Dietry Pattern and Lead Levels in Pregnancy

Start date: April 1, 1991
Phase: N/A
Study type: Observational

During pregnancy lead crosses the placenta freely and can have adverse effects on the fetus, with the potential for life-long impact on the child. Identification of dietary patterns and food groups in pregnancy in relation to measures of lead status could provide a more useful alternative to a nutrient-specific advice to minimise fetal exposure to lead during pregnancy. The aim is to evaluate whether dietary patterns and food groups are associated with blood lead concentrations in pregnancy.

NCT ID: NCT03355222 Completed - Stunting Clinical Trials

Using Eggshell Calcium to Mitigate Fluorosis in Ethiopia

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

Mothers and young children in rural Ethiopia lack sufficient nutrition, and a compounding factor is presence of high levels of fluoride (> 5-10 mg/day) affecting body functions. Interventions involving chickens to provide eggs and eggshell (a source of calcium) are one solution. The overall purpose is to examine how increasing dietary calcium by using eggshell powder (ESP) reduces fluoride (F) absorption in women. It is known calcium binds F to prevent its absorption but application of this to a community based study has not been tested. The aim is to provide chickens to produce eggs for young children and to provide ESP to women (mothers). For children, an egg a day should improve growth and nutritional status. For women, the ESP provides calcium to reduce fluorosis and therefore improve function without affecting iron and zinc status. For the women, blood samples will be tested in a subsample for F, calcium, zinc and iron; urine samples will be measured for F, calcium and creatinine (to correct spot urine). Hemoglobin will be measured as an indicator of overall nutritional status in women and children. Nutritional status of young children (6-18 mo) and of their mothers prior and after the intervention (by 6 months) will be assessed. between 6 and 12 month there will be monitoring for sustainability of chilckens in the community; for continued use of egg (in children) and ESP (in women); during this time the control group will receive chickens and also undergo monitoring. The study will take place in the Rift valley of Southern Ethiopia. Identification of the knowledge, attitude and practices (KAP) of mothers on egg consumption will be done at baseline and at the end ("endline"). Caregivers will be instructed to give each child 1 egg (cooked) per day in the intervention, and one "bottle cap" of eggshell powder (1000 mg calcium) per day for themselves. Families receiving chickens will be instructed on cage construction. Throughout the study, any problems arising in keeping chickens will be recorded in order to assess the feasibility and practicality of raising chickens as way to mitigate fluorosis and improve nutritional status.

NCT ID: NCT03342209 Completed - Clinical trials for Environmental Exposure

Utility of High Flow Nasal Cannula in CO Toxicity

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

determination of the half-life of COHb in CO-poisoned patients with high flow nasal oxygen therapy in the ED.

NCT ID: NCT03314909 Not yet recruiting - Poisoning Clinical Trials

Initial Hemopurification Strategy for Acute Paraquat Poisoning in Adults

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

HeSAPP is a single-center, non-blinded, parallel-group randomized controlled trial studying the hemopurification strategy for acute paraquat(PQ) poisoned patients. The intervention to be investigated include hemodialysis (HD), hemoperfusion (HP), combined hemoperfusion-hemodialysis concurrent therapy (HP-HD) and conservative therapy. The object of the present trial is to investigate whether hemopurification therapy can reduce mortality compared with conservative therapy.

NCT ID: NCT03256383 Recruiting - Lead Poisoning Clinical Trials

Plan for Testing Fingerstick Bloods on Magellan Systems

Start date: July 31, 2017
Phase: N/A
Study type: Observational

This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.

NCT ID: NCT03203213 Completed - Clinical trials for Poisoning by Psychoactive Substances

Musitox® Project: Consumption of Psychoactive Substances at Music Festivals in Aquitaine

Musitox®
Start date: June 30, 2017
Phase: N/A
Study type: Interventional

Poisoning by psychoactive substances is increasingly common in Europe and can be responsible for deaths. These substances, also called "festive drugs", circulate among other places in festive gatherings (night clubs, concerts, free music, feria, etc.). The main objective of this study is to determine the molecules that circulate in festive events in Aquitaine, in order to implement prevention actions by looking at whether the circulating substances vary with the style of event.

NCT ID: NCT03127657 Completed - Clinical trials for Chronic Arsenic Poisoning

Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion

Start date: January 17, 2016
Phase: Phase 2
Study type: Interventional

Cock's comb extract is rich in hyaluronic acid, which is used as viscosupplementation injection and oral supplementation for osteoarthritis. Hyaluronic acid acts as humectants and topical moisturizing agent to the skin due to excellent moisturizing property. It has anti-inflammatory effect and used in the treatment of ulcer healing and to reduce the intensity of radioepithelitis. It is also used as a topical vehicle for the delivery of drug to the skin in actinic keratosis. In the case of arsenical keratotic nodule, topical application of hyaluronic acid may tends to decrease keratosis by repeated hydration of the skin. Therefore, the study will be conducted to determine any beneficial effect of topical application of cock's comb extract in the treatment of the patients with severe palmar arsenical keratosis.

NCT ID: NCT03030833 Completed - Clinical trials for Carbon Monoxide Poisoning

Dysfunctional Hemoglobin Pulse Oximetry

Start date: February 6, 2017
Phase: N/A
Study type: Observational

The purpose of the study is to assess device performance in the presence of carbon monoxide.